Associate Professor of Clinical Cardiology
Houston, Texas, United States
Arvind Bhimaraj, MD, MPH, FACC, FHFSA, is a nationally recognized advanced heart failure and transplant cardiologist and System Director of Advanced Heart Failure at Houston Methodist. He also directs the Bradley Z. Naifeh Amyloidosis Clinical and Research Program and Heart Failure Disease Management Services, leading initiatives that have improved quality metrics, care transitions, and interdisciplinary delivery.
Dr. Bhimaraj earned his medical degree from Gandhi Medical College and an MPH from the University of Kansas Medical Center. He completed internal medicine at Drexel University, cardiology at John H. Stroger, Jr. Hospital of Cook County, and advanced heart failure and transplant fellowships at Cleveland Clinic. Since joining Houston Methodist in 2011, he has held multiple leadership roles, including Interim Chief of Heart Failure and Medical Director of the Heart Transplant and LVAD programs.
He designed a heart failure quality and data infrastructure that contributed to Houston Methodist’s AHA Get With The Guidelines Gold Plus recognition. He has developed EPIC-based phenotypic-genotypic registries supporting research in cardiac remodeling, immune-genetic interactions, and patient-centered modeling, forming a platform for AI-driven risk stratification and therapeutic targeting.
An active investigator, he leads NIH-, DoD-, industry-, and foundation-funded studies, including multi-omics work in transplantation, nano-delivery for genetic modulation, non-myocyte myocardial recovery, cardiogenic shock, and pressure-volume physiology. A TEACH-certified educator, he uses PV loop simulation to train fellows and national audiences.
He founded a patient-focused heart failure conference and volunteer program, now patient-led, and has held national roles with HFSA and ACC. He directs a multidisciplinary amyloidosis program and annual symposium. Internationally, he serves as visiting adjunct faculty at Tecnológico de Monterrey, mentors translational research, and collaborates on heart failure program development in India and Mexico.
His career integrates clinical care, systems innovation, and data science to transform heart failure management and prevention.
Disclosure information not submitted.
Session 2: Heart Failure-Related Cardiogenic Shock - Getting Granular (Accredited)
Thursday, March 5, 2026
3:25 PM - 4:55 PM CST
Does a Stabilized Crash and Burn Patient on pMCS Deserve to be downgraded on UNOS List awaiting OHT?
Thursday, March 5, 2026
4:10 PM - 4:17 PM CST